Application of nucleic acid amplification techniques for blood donation screening

Infusionstherapie und Transfusionsmedizin

Volumn 25, Issue 2-3, 1998, Pages 86-90

  Nubling C M ^a   Seitz, R ^a   Lower J ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Blood donation; Diagnostic window; NAT; PCR; Screening test

Indexed keywords

VIRUS ANTIGEN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; EARLY DIAGNOSIS; GENE AMPLIFICATION; INCIDENCE; MASS SCREENING; SCREENING TEST; VIRUS TRANSMISSION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0031836640     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053399     Document Type: Article

References (17)

1. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC: Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
2. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM, Brun-Vézinet F, Simon F: HIV-l/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-1394.
3. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68: 1581-1585.
4. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV: The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996;2:1104-1108.
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Marcs A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327: 1899-1905.
6. Schmidt WN, Wu P, Cederna J, Mitros FA, LaBrecque DR, Stapleton JT: Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. J Infect Dis 1997;17:627-633.
7. Prince AM, Scheffel JW, Moore B: A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase. Transfusion 1997;37:211-214.
8. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
9. Lelie PN, Cuypers HTM, Rogers P, Over J, Schuitemaker J, Quint WGV: Standardisation of viral nucleic acid amplification methodology in blood safety testing: A risk benefit analysis. 1997 (submitted for publication).
10. Glück D, Maurer C, Kubanek B: Infektionsmarker bei Blutspenden. Infusionsther Transfusionsmed 1997;24:167-170.
11. Riggert J, Schwartz DWM, Uy A, Simson G, Jelinek F, Fabritz H, Mayr WR, Köhler M: Risk of hepatitis C virus (HCV) transmission by anti-HCVnegative blood components in Austria and Germany. Ann Hematol 1996;7:235-239.
12. Nübling CM, Willkommen H, Löwer J: Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 1995;345:1174.
13. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. MMWR 1994;43: 505-509.
14. Nübling CM, Löwer J: The role of nucleic acid amplification techniques (NATs) in viral safety testing of blood and blood products. Biotest Bull 1997;5:377-381.
15. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-724.
16. Saldanha J, Minor P: Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang 1996;70:148-151.
17. Quint WGV, Heijtink RA, Gerlich WH, Niesters HGM: Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol 1995;33:225-228.